Discrepancy between biological activity of thymosin and its cyclic nucleotide-modulating activity

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Cyclic adenosine 3':5'-monophosphate (cAMP) and cyclic 3':5'-guanosine monophosphate (cGMP) are crucial second messengers in cellular signaling.
• Lymphocytes, including cord blood lymphocytes (CBL) and adult peripheral blood lymphocytes (PBL), play key roles in immune responses.
• Thymosins are peptides involved in immune system regulation.

Purpose of the Study:

• To investigate the effects of thymosin V-1 and V-2 on cAMP and cGMP levels in human lymphocytes.
• To compare the responses of adult PBL and CBL to thymosin stimulation.
• To elucidate the potential mechanism of thymosin action on lymphocyte cyclic nucleotide metabolism.

Main Methods:

• Measurement of intracellular cAMP and cGMP concentrations in PBL and CBL.
• Stimulation of lymphocytes with thymosin V-1 and V-2 at specified concentrations.
• Inhibition of cAMP phosphodiesterase using isobutyl methylxanthine to confirm the source of cAMP increase.

Main Results:

• Thymosin V-1 significantly increased cAMP levels in adult PBL by 85% within 1 minute, but had no effect on CBL.
• CBL exhibited nine times higher basal cAMP levels compared to PBL.
• Neither thymosin V-1 nor V-2 affected cGMP levels in either cell type. Thymosin V-2 also increased cAMP in adult PBL.
• The cAMP-increasing effect of thymosin V-1 was observed even with complete inhibition of cAMP phosphodiesterase.

Conclusions:

• Thymosin V-1 and V-2 stimulate cAMP production in adult PBL, but not in CBL, despite higher basal cAMP in CBL.
• The observed increase in cAMP is likely due to the stimulation of adenylate cyclase rather than inhibition of phosphodiesterase.
• Thymosin's mechanism of action may involve direct activation of adenylate cyclase in specific lymphocyte populations.